Structural determinants of GAD antigenicity

Molecular Immunology

Volumn 47, Issue 2-3, 2009, Pages 493-505

  Arafat, Yasir ^a   Fenalti, Gustavo ^a   Whisstock, James C ^a   Mackay, Ian R ^a   Garcia de la Banda, Maria ^a   Rowley, Merrill J ^a   Buckle, Ashley M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Autoantigen; Epitope; Glutamic acid decarboxylase; Protein protein interactions; Type 1 diabetes

Indexed keywords

AMINO ACID; AUTOANTIBODY; AUTOANTIGEN; EPITOPE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; ISOPROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIGENICITY; ARTICLE; AUTOIMMUNE DISEASE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISEASE MARKER; ENZYME MECHANISM; ENZYME STRUCTURE; HYDROPHOBICITY; INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION;

AMINO ACIDS; ANTIGENS; BIOCATALYSIS; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; GLUTAMATE DECARBOXYLASE; HUMANS; HYDROPHOBICITY; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PYRIDOXAL PHOSPHATE; STATIC ELECTRICITY; STRUCTURAL HOMOLOGY, PROTEIN; SURFACE PROPERTIES; THERMODYNAMICS;

EID: 70450224671     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.08.022     Document Type: Article

References (70)

1. Albeck S., Unger R., and Schreiber G. Evaluation of direct and cooperative contributions towards the strength of buried hydrogen bonds and salt bridges. J. Mol. Biol. 298 (2000) 503-520
2. Argos P. An investigation of protein subunit and domain interfaces. Protein Eng. 2 (1988) 101-113
3. Arnold K., Bordoli L., Kopp J., and Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22 (2006) 195-201
4. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., and De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347 (1990) 151-156
5. Baker N.A. Poisson-Boltzmann methods for biomolecular electrostatics. Methods Enzymol. 383 (2004) 94-118
6. Battaglioli G., Liu H., and Martin D.L. Kinetic differences between the isoforms of glutamate decarboxylase: implications for the regulation of GABA synthesis. J. Neurochem. 86 (2003) 879-887
7. Binder K.A., Banga J.P., Madec A.M., Ortqvist E., Luo D., and Hampe C.S. Epitope analysis of GAD65Ab using fusion proteins and rFab. J. Immunol. Methods 295 (2004) 101-109
8. Black S.D., and Mould D.R. Development of hydrophobicity parameters to analyze proteins which bear posttranslational or cotranslational modifications. Anal. Biochem. 193 (1991) 72-82
9. Bordner A.J., and Abagyan R. Statistical analysis and prediction of protein-protein interfaces. Proteins 60 (2005) 353-366
10. Braden B.C., and Poljak R.J. Structural features of the reactions between antibodies and protein antigens. FASEB J. 9 (1995) 9-16
11. Bradford J.R., and Westhead D.R. Improved prediction of protein-protein binding sites using a support vector machines approach. Bioinformatics 21 (2005) 1487-1494
12. Butler M.H., Solimena M., Dirkx Jr. R., Hayday A., and De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J. Exp. Med. 178 (1993) 2097-2106
13. Caffrey D.R., Somaroo S., Hughes J.D., Mintseris J., and Huang E.S. Are protein-protein interfaces more conserved in sequence than the rest of the protein surface?. Protein Sci. 13 (2004) 190-202
14. Chen C.H., Wu S.J., and Martin D.L. Structural characteristics of brain glutamate decarboxylase in relation to its interaction and activation. Arch. Biochem. Biophys. 349 (1998) 175-182
15. Chothia C., and Janin J. Principles of protein-protein recognition. Nature 256 (1975) 705-708
16. Christen M., Hunenberger P.H., Bakowies D., Baron R., Burgi R., Geerke D.P., Heinz T.N., Kastenholz M.A., Krautler V., Oostenbrink C., Peter C., Trzesniak D., and van Gunsteren W.F. The GROMOS software for biomolecular simulation: GROMOS05. J. Comput. Chem. 26 (2005) 1719-1751
17. Davies D.R., and Cohen G.H. Interactions of protein antigens with antibodies. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 7-12
18. DeLano, W.L., 2002. The PyMOL Molecular Graphics System. DeLano Scientific, Palo Alto, CA, USA. http://www.pymol.org.
19. Fenalti G., Hampe C.S., O'Connor K., Banga J.P., Mackay I.R., Rowley M.J., and El-Kabbani O. Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11. Mol. Immunol. (2006)
20. Fenalti G., Law R.H., Buckle A.M., Langendorf C., Tuck K., Rosado C.J., Faux N.G., Mahmood K., Hampe C.S., Banga J.P., Wilce M., Schmidberger J., Rossjohn J., El-Kabbani O., Pike R.N., Smith A.I., Mackay I.R., Rowley M.J., and Whisstock J.C. GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat. Struct. Mol. Biol. 14 (2007) 280-286
21. Fenalti G., Hampe C.S., Arafat Y., Law R.H., Banga J.P., Mackay I.R., Whisstock J.C., Buckle A.M., and Rowley M.J. COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity. Diabetes 57 (2008) 1293-1301
22. Glaser F., Steinberg D.M., Vakser I.A., and Ben-Tal N. Residue frequencies and pairing preferences at protein-protein interfaces. Proteins 43 (2001) 89-102
23. Hampe C.S., Ortqvist E., Persson B., Schranz D.B., and Lernmark A. Glutamate decarboxylase (GAD) autoantibody epitope shift during the first year of type 1 diabetes. Hormone Metab. Res. 31 (1999) 553-557
24. Haste Andersen P., Nielsen M., and Lund O. Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci. 15 (2006) 2558-2567
25. Hsu C.C., Thomas C., Chen W., Davis K.M., Foos T., Chen J.L., Wu E., Floor E., Schloss J.V., and Wu J.Y. Role of synaptic vesicle proton gradient and protein phosphorylation on ATP-mediated activation of membrane-associated brain glutamate decarboxylase. J. Biol. Chem. 274 (1999) 24366-24371
26. James J.A., and Harley J.B. B-cell epitope spreading in autoimmunity. Immunol. Rev. 164 (1998) 185-200
27. Jansonius J.N. Structure, evolution and action of vitamin B6-dependent enzymes. Curr. Opin. Struct. Biol. 8 (1998) 759-769
28. Jones S., and Thornton J.M. Protein-protein interactions: a review of protein dimer structures. Prog. Biophys. Mol. Biol. 63 (1995) 31-65
29. Jones S., and Thornton J.M. Principles of protein-protein interactions. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 13-20
30. Jones S., and Thornton J.M. Analysis of protein-protein interaction sites using surface patches. J. Mol. Biol. 272 (1997) 121-132
31. Jones S., and Thornton J.M. Prediction of protein-protein interaction sites using patch analysis. J. Mol. Biol. 272 (1997) 133-143
32. 2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J. Exp. Med. 180 (1994) 595-606
33. Kohno Y., Hiyama Y., Shimojo N., Niimi H., Nakajima H., and Hosoya T. Autoantibodies to thyroid peroxidase in patients with chronic thyroiditis: effect of antibody binding on enzyme activities. Clin. Exp. Immunol. 65 (1986) 534-541
34. Kulkarni-Kale U., Bhosle S., and Kolaskar A.S. CEP: a conformational epitope prediction server. Nucleic Acids Res. 33 (2005) W168-W171
35. Lijnzaad P., and Argos P. Hydrophobic patches on protein subunit interfaces: characteristics and prediction. Proteins 28 (1997) 333-343
36. Lo Conte L., Chothia C., and Janin J. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285 (1999) 2177-2198
37. Manns M., Zanger U., Gerken G., Sullivan K.F., Meyer zum Buschenfelde K.H., Meyer U.A., and Eichelbaum M. Patients with type II autoimmune hepatitis express functionally intact cytochrome P-450 db1 that is inhibited by LKM-1 autoantibodies in vitro but not in vivo. Hepatology 12 (1990) 127-132
38. Martin D.L., Liu H., Martin S.B., and Wu S.J. Structural features and regulatory properties of the brain glutamate decarboxylases. Neurochem. Int. 37 (2000) 111-119
39. Morreale A., de la Cruz X., Meyer T., Gelpi J.L., Luque F.J., and Orozco M. Partition of protein solvation into group contributions from molecular dynamics simulations. Proteins 58 (2005) 101-109
40. Myers M.A., Davies J.M., Tong J.C., Whisstock J., Scealy M., Mackay I.R., and Rowley M.J. Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling. J. Immunol. 165 (2000) 3830-3838
41. Neuvirth H., Raz R., and Schreiber G. ProMate: a structure based prediction program to identify the location of protein-protein binding sites. J. Mol. Biol. 338 (2004) 181-199
42. O'Connor K.H., Banga J.P., Darmanin C., El-Kabbani O., Mackay I.R., and Rowley M.J. Characterisation of an autoreactive conformational epitope on GAD65 recognised by the human monoclonal antibody b78 using a combination of phage display, in vitro mutagenesis and molecular modelling. J. Autoimmun. 26 (2006) 172-181
43. Padoa C.J., Banga J.P., Madec A.M., Ziegler M., Schlosser M., Ortqvist E., Kockum I., Palmer J., Rolandsson O., Binder K.A., Foote J., Luo D., and Hampe C.S. Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs. Diabetes 52 (2003) 2689-2695
44. Paus D., and Winter G. Mapping epitopes and antigenicity by site-directed masking. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 9172-9177
45. Percudani R., and Peracchi A. A genomic overview of pyridoxal-phosphate-dependent enzymes. EMBO Rep. 4 (2003) 850-854
46. Pittock S.J., Yoshikawa H., Ahlskog J.E., Tisch S.H., Benarroch E.E., Kryzer T.J., and Lennon V.A. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo. Clin. Proc. 81 (2006) 1207-1214
47. Plotz P.H. The autoantibody repertoire: searching for order. Nat. Rev. Immunol. 3 (2003) 73-78
48. Powers A.C., Bavik K., Tremble J., Daw K., Scherbaum W.A., and Banga J.P. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders. Clin. Exp. Immunol. 118 (1999) 349-356
49. Raju R., Foote J., Banga J.P., Hall T.R., Padoa C.J., Dalakas M.C., and Ortqvist E. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients. J. Immunol. 175 (2005) 7755-7762
50. Richter W., Endl J., Eiermann T.H., Brandt M., Kientsch-Engel R., Thivolet C., Jungfer H., and Scherbaum W.A. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 8467-8471
51. Richter W., Shi Y., and Baekkeskov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 2832-2836
52. Rini J.M., Schulze-Gahmen U., and Wilson I.A. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 255 (1992) 959-965
53. Rowley M.J., McNeilage L.J., Armstrong J.M., and Mackay I.R. Inhibitory autoantibody to a conformational epitope of the pyruvate dehydrogenase complex, the major autoantigen in primary biliary cirrhosis. Clin. Immunol. Immunopathol. 60 (1991) 356-370
54. Rubinstein N.D., Mayrose I., Halperin D., Yekutieli D., Gershoni J.M., and Pupko T. Computational characterization of B-cell epitopes. Mol. Immunol. 45 (2008) 3477-3489
55. Saha S., and Raghava G.P. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 65 (2006) 40-48
56. Saiz A., Blanco Y., Sabater L., Gonzalez F., Bataller L., Casamitjana R., Ramio-Torrenta L., and Graus F. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131 (2008) 2553-2563
57. Schlosser M., Banga J.P., Madec A.M., Binder K.A., Strebelow M., Rjasanowski I., Wassmuth R., Gilliam L.K., Luo D., and Hampe C.S. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes. Diabetologia 48 (2005) 922-930
58. Schwartz H.L., Chandonia J.M., Kash S.F., Kanaani J., Tunnell E., Domingo A., Cohen F.E., Banga J.P., Madec A.M., Richter W., and Baekkeskov S. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J. Mol. Biol. 287 (1999) 983-999
59. Sheinerman F.B., and Honig B. On the role of electrostatic interactions in the design of protein-protein interfaces. J. Mol. Biol. 318 (2002) 161-177
60. Sinha N., Li Y., Lipschultz C.A., and Smith-Gill S.J. Understanding antibody-antigen associations by molecular dynamics simulations: detection of important intra- and inter-molecular salt bridges. Cell. Biochem. Biophys. 47 (2007) 361-375
61. Stocker U., and van Gunsteren W.F. Molecular dynamics simulation of hen egg white lysozyme: a test of the GROMOS96 force field against nuclear magnetic resonance data. Proteins 40 (2000) 145-153
62. Syren K., Lindsay L., Stoehrer B., Jury K., Luhder F., Baekkeskov S., and Richter W. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J. Immunol. 157 (1996) 5208-5214
63. Teoh K.L., Fida S., Rowley M.J., and Mackay I.R. Autoantigenic reactivity of diabetes sera with a hybrid glutamic acid decarboxylase GAD67-65 molecule GAD67(1-101)/GAD65(96-585). Autoimmunity 28 (1998) 259-266
64. Tree T.I., Morgenthaler N.G., Duhindan N., Hicks K.E., Madec A.M., Scherbaum W.A., and Banga J.P. Two amino acids in glutamic acid decarboxylase act in concert for maintenance of conformational determinants recognised by Type I diabetic autoantibodies. Diabetologia 43 (2000) 881-889
65. Tremble J., Morgenthaler N.G., Vlug A., Powers A.C., Christie M.R., Scherbaum W.A., and Banga J.P. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes. J. Clin. Endocrinol. Metab. 82 (1997) 2664-2670
66. Tsodikov O.V., Record Jr. M.T., and Sergeev Y.V. Novel computer program for fast exact calculation of accessible and molecular surface areas and average surface curvature. J. Comput. Chem. 23 (2002) 600-609
67. Vakser I.A., and Aflalo C. Hydrophobic docking: a proposed enhancement to molecular recognition techniques. Proteins 20 (1994) 320-329
68. Van de Water J., Fregeau D., Davis P., Ansari A., Danner D., Leung P., Coppel R., and Gershwin M.E. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J. Immunol. 141 (1988) 2321-2324
69. Young L., Jernigan R.L., and Covell D.G. A role for surface hydrophobicity in protein-protein recognition. Protein Sci. 3 (1994) 717-729
70. Zhou H.X., and Shan Y. Prediction of protein interaction sites from sequence profile and residue neighbor list. Proteins 44 (2001) 336-343